FDA Approves Austedo for Tardive DyskinesiaApprovals, Chorea, FDA, FDA/Regulatory, Gastrointestinal Conditions, Huntington's Disease, Mental Health, Movement Disorders, New Indications, Tardive DyskinesiaTeva Pharmaceutical Industries Ltd. announced that the U.S. FDA approved Austedo (deutetrabenazine) tablets for the treatment of tardive dyskinesia in adults. Read more August 30, 2017/by Business Wire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Business Wire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Business Wire2017-08-30 15:53:322017-08-30 18:22:42FDA Approves Austedo for Tardive Dyskinesia